![](/images/ico/ico_close.png)
![](/images/ico/ico3.png)
Period of time: 2014年1期
Publisher: Informa Healthcare
Founded in: 1996
Total resources: 42
ISSN: 1472-8214
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Emerging Drugs,volume 16,issue 1
Menu
![](/images/ico/ico5.png)
Emerging drugs for the treatment of tuberculosis
By Yew Wing Wai,Cynamon Michael,Zhang Ying in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Emerging antiarrhythmic agents: a personal view from the Far East
By Hashimoto Keitaro in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
By Denas Gentian,Pengo Vittorio in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Emerging drugs for Waldenströöm's macroglobulinemia
By Kastritis Efstathios,Terpos Evangelos,Dimopoulos Meletios A in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Emerging Bcl-2 inhibitors for the treatment of cancer
By Azmi Asfar S,Wang Zhiwei,Philip Philip A,Mohammad Ramzi M,Sarkar Fazlul H in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Emerging therapeutics for primary peritoneal cancer
By Slomovitz Brian M,Worley Michael J,Markman Maurie,Coleman Robert L in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Current status of agents active against the T315I chronic myeloid leukemia phenotype
By Burke Aine Carol,Swords Ronan T,Kelly Kevin,Giles Francis J in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Emerging drugs for Guillain-Barréé syndrome
By Walgaard Christa,Jacobs Bart C,van Doorn Pieter A in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Treatment of non-alcoholic fatty liver disease with focus on emerging drugs
By Marchesini Giulio,Moscatiello Simona,Agostini Federica,Villanova Nicola,Festi Davide in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.![](/images/ico/ico5.png)
Emerging drugs for ocular hypertension
By Lee Anne J,Goldberg Ivan in (2011)
Expert Opinion on Emerging Drugs,volume 16,issue 1 , Vol. 16, Iss. 1, 2011-03 , pp.